[1]
2025. Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach. Asian Journal of Diabetology. 25, 2 (Nov. 2025), 6–20. DOI:https://doi.org/10.59793/j8y5zv46.